Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1995
05/30/1995CA1335712C Carcas quality
05/28/1995CA2136704A1 Medicinal aerosol formulation
05/26/1995WO1995014102A1 Recombinant viruses coding for thymidine kinase in gene therapy
05/26/1995WO1995014101A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
05/26/1995WO1995014095A1 Endothelin-converting enzyme
05/26/1995WO1995014091A2 Compositions and methods for utilizing conditionally lethal genes
05/26/1995WO1995014089A2 Cck-2, a receptor tyrosine kinase
05/26/1995WO1995014088A1 Mck-10 (mammary carcinoma kinase), a receptor tyrosine kinase
05/26/1995WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995WO1995014082A1 Delivery of gene products via mesangial cells
05/26/1995WO1995014078A1 Bioengineered human blood cells
05/26/1995WO1995014041A1 Reconstituted human antibody against human medulloblastomatous cell
05/26/1995WO1995014039A1 Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (lbp) and methods of their use
05/26/1995WO1995014038A2 Purification of hemoglobin
05/26/1995WO1995014037A1 Transparent liquid for encapsulated drug delivery
05/26/1995WO1995014036A1 Carbohydrate-containing compounds which bind to carbohydrate binding receptors
05/26/1995WO1995014033A1 Novel dipeptide derivatives
05/26/1995WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995WO1995013831A1 Antibody to ocular and vaginal surface epithelium
05/26/1995WO1995013830A1 Method for inhibiting angiogenesis using heparinase
05/26/1995WO1995013829A1 Use of solutions of cross-linked haemoglobin in combating septic and haemorrhagic shock in mammals
05/26/1995WO1995013828A1 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins
05/26/1995WO1995013827A1 A method for preventing or controlling cataract
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995WO1995013825A1 TRANSDERMAL COMPOSITION OF N-[N-[5-[4-(AMINOIMINOMETHYL)PHENYL]-1-OXOPENTYL]-L-α-ASPARTYL]-L-PHENYLALANINE OR ITS ESTERS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
05/26/1995WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995WO1995013823A1 Method of treating neurological disorders
05/26/1995WO1995013822A1 Modified arginine-containing lytic peptides and method of making the same by glyoxylation
05/26/1995WO1995013821A1 αvβ3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
05/26/1995WO1995013819A1 Sulfated ligands for l-selectin and methods of preventing sulfate addition
05/26/1995WO1995013818A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995WO1995013817A1 Endothelin converting enzyme inhibitors
05/26/1995WO1995013802A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995WO1995013767A1 Osteogenic product and process
05/26/1995WO1995013701A1 Novel fas protein and methods of use thereof
05/26/1995WO1995011977A3 A NEW RIBOSOME-INACTIVATING PROTEIN ISOLATED FROM THE PLANT $i(BRYONIA DIOICA)
05/26/1995WO1994027584A3 Arylating medicaments
05/26/1995CA2187152A1 Cck-2, a receptor tyrosine kinase
05/26/1995CA2184485A1 Bioengineered human blood cells
05/26/1995CA2176934A1 Method for inhibiting angiogenesis using heparinase
05/26/1995CA2176819A1 A method for detection of alterations in the dna mismatch repair pathway
05/26/1995CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995CA2176721A1 Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor
05/26/1995CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995CA2176708A1 Method of treating neurological disorders
05/26/1995CA2176585A1 Recombinant adenoviruses for gene therapy in cancers
05/26/1995CA2176575A1 Novel fas protein and methods of use thereof
05/26/1995CA2176507A1 Endothelin-converting enzyme
05/26/1995CA2176462A1 Transdermal composition of n-¬n-¬5-¬4-(aminoiminomethyl)phenyl|-1-oxopentyl|-l-.alpha.-aspartyl|-l-phenylalanine or its esters and their pharmaceutically acceptable salts
05/26/1995CA2176220A1 A method for treating cardiac dysfunction and pharmaceutical compositions useful therefor
05/26/1995CA2176014A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
05/26/1995CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995CA2153482A1 Delivery of gene products via mesangial cells
05/26/1995CA2109989A1 Polymerized collagen-based anti-fibroid composition
05/24/1995EP0654272A1 Alimentary canal cell activator
05/24/1995EP0654268A1 A method to reverse the phenotype of transformed cells by the transcription factor IRF-1
05/24/1995EP0654088A1 Novel flk-2 and analogs
05/24/1995EP0654084A1 Molecular cloning of the genes reponsible for collagenase production from clostridium histolyticum
05/24/1995EP0654083A1 Ptp-d subfamily of protein tyrosine phosphatases
05/24/1995EP0654080A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE
05/24/1995EP0654078A1 A thrombin blood fraction for use in a medical procedure
05/24/1995EP0654077A1 Method and reagent for treatment of animal diseases
05/24/1995EP0654046A1 Auto-cross-linked gellan gum
05/24/1995EP0654042A1 Amylin muteins
05/24/1995EP0654041A1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
05/24/1995EP0654040A1 Pharmaceutical composition containing botulinum b complex
05/24/1995EP0653990A1 Timing valve for the discontinuous metering of a volume flow.
05/24/1995EP0653943A1 Targeting somatic gene therapy to joints
05/24/1995EP0653942A1 Morphogen-induced nerve regeneration and repair
05/24/1995EP0653941A1 Targeted delivery of growth factors for bone regeneration
05/24/1995EP0653940A1 Glial mitogenic factors, their preparation and use
05/24/1995EP0653939A1 Use of a hymenoptera venom for the manufacture of a medicament for treating dna virus infections
05/24/1995EP0630275A4 Fibrin sealant delivery method.
05/24/1995EP0630238A4 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa).
05/24/1995EP0604560A4 Human cyclin e.
05/24/1995EP0586392B1 Method for separating a vegetable compound
05/24/1995EP0574394B1 Substances of polypeptide nature useful in human therapy
05/24/1995EP0548194B1 Monoclonal antibody active against the interleukin-2 receptor
05/24/1995EP0520029B1 Methods and compositions for the treatment of malignancies in which a protein kinase is associated
05/24/1995EP0447468B1 Ancrod proteins, their production and use
05/24/1995EP0440709B1 Thrombolytic agents with modified kringle domains
05/24/1995EP0357767B1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates
05/24/1995DE4340111A1 New peptide(s) which inhibit tumour necrosis factor alpha
05/24/1995DE4339848A1 Compsn. contg. lithium salts and angiotensin-II-receptor antagonists
05/24/1995CA2135587A1 Antitumor antibiotics
05/23/1995US5418222 Multi-layered collagen film compositions for delivery of proteins and methods of using same
05/23/1995US5418219 Pharmaceutical composition for treatment of adult respiratory distress syndrome containing human ANP
05/23/1995US5418218 Controlling food intake
05/23/1995US5418192 Production of IFN using DA15 peptide
05/23/1995US5418159 Leukaemia inhibitory factor from livestock species and use thereof to enhance implantation and development of embryonic cells
05/23/1995US5418157 Recombinant 68,000 dalton collagenase of Clostridium histolyticum
05/23/1995US5418135 Method of inhibiting binding of PDGF to a PDGF receptor by biosynthetic PDGF antagonists
05/23/1995US5418130 Phosphonium or ammonium halo-psoralen
05/23/1995US5418129 Antitumor
05/23/1995US5417986 Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
05/23/1995US5417972 Method of killing B-cells in a complement independent and an ADCC independent manner using antibodies which specifically bind CDIM
05/23/1995US5417970 Purity
05/23/1995CA1335666C Extraction and purification of an anticoagulant principle from the south american leech, haementeria ghilianii
1 ... 2845 2846 2847 2848 2849 2850 2851 2852 2853 2854 2855 2856 2857 2858 2859 2860 2861 2862 2863 2864 2865 ... 3163